- FOUNDED 1991
Overview
The Clinical Trials and Research Professionals Group (CTRPG) is committed to achieving and promoting excellence in clinical cancer research by supporting research professionals through education, information, leadership, and by providing networking opportunities.
Members of CTRPG are professionals involved in clinical cancer research involved in the collection and management of oncology data. Membership is open, but not limited to, clinical trial coordinators, investigators and research nurses, clinical trial managers, data managers, clinical research associates and health information managers who support clinical cancer research.
In alliance with the interests and objectives of COSA, the CTRPG aims to:
- promote and maintain the quality standards of clinical trial coordination in oncology research in Australia and New Zealand
- respond to the dynamic needs of members by providing continuing education
- provide a forum for discussion and exchange of experiences and information
- strengthen relationships across professional disciplines and with cooperative oncology groups
- foster research within the scope of clinical trials management
The agreed objectives of the CTRPG are documented in Group Terms of Reference which include the establishment of an Executive Committee to maintain a strategic focus for the Group.
All members of the CTRPG Executive are committed to ensuring that our Group continues to be relevant to our membership and fosters research within the scope of clinical trials management.
Group information
Clinical Trials and Research Professionals Group Terms of Reference – Council approved 6 August 2021
What’s the latest
Group Chair

Group Chair
Adam Stoneley
Clinical Trials & Research Professionals Group Chair
Join Australia's leading oncology community & make an impact
Become a COSA memberTwitter
@COSAoncology
Follow

COSAoncology 15 hours ago
The Tom Reeve Award recognises a national leader who's made significant contributions to cancer care. The award will be presented at COSA-IPOS 2025 in Adelaide in November where the recipient is invited to deliver an address. Nominations closing 14 July. bit.ly/3hIXWcV
Read More >
COSAoncology 4 days ago
Have you renewed your COSA membership yet? You might like to renew before 30 June 2025: bit.ly/4cI0nc3
Read More >
COSAoncology 6 days ago
Our June member newsletter is out now. Check your inbox for the latest COSA news and updates including new resources, events, opportunities and peer-reviewed journal articles. Or log in and view it online anytime at bit.ly/4kRIRpp
Read More >
COSAoncology 7 days ago
COSA is the national oncology community bringing together multidisciplinary health professionals across all cancers to advance care and improve outcomes. More on member benefits here: bit.ly/3BwXvwL
Read More >
COSAoncology 14 days ago
If you selected automatic renewal, expect to see an email from COSA today. Please check your details in the email, and update your billing in your COSA account if needed. bit.ly/4cI0nc3
Read More >
COSAoncology 14 days ago
Check out what your membership supported COSA to achieve in the last year! Renew your membership to continue collaborating with COSA: bit.ly/4cI0nc3
Read More >
COSAoncology 18 days ago
COSA is a truly multidisciplinary community providing opportunities to connect with leaders in cancer healthcare, build networks and collaborations, access professional development, drive advocacy and facilitate research. Join or renew today: cosa.org.au
Read More >
COSAoncology 20 days ago
Did you know COGNO members can join COSA at a discounted rate? Thank you to @cogno_trials for continuing Affiliated organisation membership with COSA. bit.ly/3s5mOC6
Read More >
COSAoncology 20 days ago
Thank you @MASC_Trials for continuing your Affiliated organisation membership with COSA. Don’t forget, MASC Trials members can join COSA at a discounted rate. bit.ly/3s5mOC6
Read More >
COSAoncology 21 days ago
Congratulations COSA members and friends who were recognised with #KingsBirthdayHonours including oncology nurse and researcher, Catherine Johnson AM, and radiation oncologists and researchers, Prof Michael Poulsen AM and Prof Gerard Fogarty OAM. These honours are well deserved
Read More >